Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence

Treatments for hepatitis C virus (HCV) have advanced greatly, becoming more efficacious with fewer adverse events, due to the availability of direct-acting antiviral agents, which target specific steps in the HCV life cycle. Recently, a combination regimen consisting of the HCV nonstructural protein...

Full description

Saved in:
Bibliographic Details
Published in:Drug Des Devel Ther
Main Authors: Morikawa, Kenichi, Nakamura, Akihisa, Shimazaki, Tomoe, Sakamoto, Naoya
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2018
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6132225/
https://ncbi.nlm.nih.gov/pubmed/30233138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S133697
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items